Coagulation monitoring to prevent hemostatic complications in extra corporeal membrane oxygenation in kids.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28010

Enrollment

160

Registered

2019-03-25

Start date

2019-03-25

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Any, requiring ECMO

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Child (<18 years) on ECMO

Exclusion criteria

Exclusion criteria: > 24 hours on ECMO No informed consent

Design outcomes

Primary

Measure	Time frame
The first hemostatic complication in the first 14 days of ECMO therapy and the test results of conventional and viscoelastic coagulation tests.	—

Secondary

Measure	Time frame
Incidence of hemostatic complications and the survival of children on ECMO with and with hemostatic complications.	—

Contacts

Public ContactJoppe Drop

ErasmusMC

j.drop@erasmusmc.nl01070436084

Outcome results